Response to growth hormone in patients with RNPC3 mutations

After 6 years of Growth Hormone (GH) therapy, three patients with a defect in minor spliceosome mRNA processing leading to an incompletely understood GH deficit present with excellent auxological response and improvement in the bone mineral density and trabecular bone structure. [Image: see text]

Uloženo v:
Podrobná bibliografie
Vydáno v:EMBO Mol Med
Hlavní autoři: Martos‐Moreno, Gabriel Á, Travieso‐Suárez, Lourdes, Pozo‐Román, Jesús, Muñoz‐Calvo, María T, Chowen, Julie A, Frilander, Mikko J, Pérez‐Jurado, Luis A, Hawkins, Federico G, Argente, Jesús
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Correspondence
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034130/
https://ncbi.nlm.nih.gov/pubmed/29866761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201809143
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky